Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118226) titled 'Prospective, observational study on predicting immunotherapy efficacy in intrahepatic cholangiocarcinoma using deep learning-based virtual multiplex immunofluorescence score' on Feb. 3.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: Shanghai Tenth People's Hospital Ethics Committee

Condition: Intrahepatic Cholangiocarcinoma (ICC)

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-02-03

Target Sample Size: Case series:200;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=309090

Disclaimer: Curated b...